Trial Profile
Randomized, open, controlled phase II clinical study of apatinib piece (AiTan) combined the Sox scheme first-line treatment of advanced gastric cancer under the background of panoramic cancer gene detection.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Feb 2017
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Gimeracil; Oteracil; Oxaliplatin; Tegafur
- Indications Gastric cancer
- Focus Therapeutic Use
- 15 Feb 2017 New trial record